PublikationsserverOtte, K., Zhao, K., Braun, M., Neubauer, A., Raifer, H., Helmprobst, F., . . . Rusch, T. (2022). Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide. Philipps-Universität Marburg. https://doi.org/10.3390/biomedicines10092145
Chicago-Zitierstil (17. Ausg.)Otte, Katharina, et al. Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide. Philipps-Universität Marburg, 2022. https://doi.org/10.3390/biomedicines10092145.
MLA-Zitierstil (9. Ausg.)Otte, Katharina, et al. Eltanexor Effectively Reduces Viability of Glioblastoma and Glioblastoma Stem-Like Cells at Nano-Molar Concentrations and Sensitizes to Radiotherapy and Temozolomide. Philipps-Universität Marburg, 2022. https://doi.org/10.3390/biomedicines10092145.